Radionetics Oncology Enters Into Strategic Agreement With Lilly

SAN DIEGO, CA - JULY 1, 2024 - Radionetics Oncology a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted …

CouponFollow Extension

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. …

pmlive.com

$140
OFF

Eli Lilly Continues Radiopharma Push With $140m Radionetics …

4 weeks from now

Jul 2, 2024 · Eli Lilly has partnered with Radionetics Oncology in a $140m deal, as the drugmaker aims to get a leg up in the burgeoning radiopharmaceuticals arena. In addition to the upfront …

pharmaceutical-technology.com

$140
OFF

Eli Lilly Enters $140M Partnership With Radionetics Oncology

4 weeks from now

Jul 4, 2024 · The strategic agreement with Eli Lilly comes shortly after the company’s $52.5 million series A fundraising in February this year. For Eli Lilly, the partnership with Radionetics …

outsourcing-pharma.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$140
OFF

Lilly Signs Another Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

Jul 15, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$140
OFF

Lilly Enters $140 Million Radiopharmaceutical Pact

4 weeks from now

Jul 11, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New …

4 weeks from now

May 21, 2024 · Drugmaker Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with biotechnology firm Aktis Oncology. Under terms of the …

radiologybusiness.com

FAQs about Radionetics Oncology Enters Into Strategic Agreement With Lilly Coupon?

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...

Does Eli Lilly own radionetics?

The arrangement with Radionetics, a San Diego-based biotechnology company, is the latest step by Lilly to build a presence in the fast-growing field. A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images ...

Why is Lilly partnering with radionetics oncology?

"Furthering our commitment to radiopharmaceutical therapies, this relationship provides access to novel GPCR targets and the discovery capabilities of Radionetics Oncology," said Jacob Van Naarden, Executive Vice President and President, Lilly Oncology. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Where is Eli Lilly headquartered 2024?

A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. ...

What's happening in the radiopharma space?

The radiopharma space has seen a frenzy of dealmaking since the end of last year, with Novartis’ $1 billion buyout of Mariana Oncology in May being a recent highlight. Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash. ...